Vivek Narayan 1,2, Julie S Barber-Rotenberg 3, In-Young Jung #,2,3,4, Simon F Lacey #,3,5, Andrew J Rech #,2,3,5,6, Megan M Davis #,3, Wei-Ting Hwang 7, Priti Lal 2,5, Erica L Carpenter 2,6, Shannon L Maude 8,9, Gabriela Plesa 3, Neha Vapiwala 1,2, Anne Chew 3, Michael Moniak 3, Ronnie A Sebro 2,10, Michael D Farwell 2,10, Amy Marshall 3, Joan Gilmore 3, Lester Lledo 3, Karen Dengel 3, Sarah E Church 11, Tyler D Hether 11, Jun Xu 3, Mercy Gohil 3, Thomas H Buckingham 2,6, Stephanie S Yee 2,6, Vanessa E Gonzalez 3, Irina Kulikovskaya 3, Fang Chen 3, Lifeng Tian 3, Kyle Tien 2,6, Whitney Gladney 3, Christopher L Nobles 4, Hayley E Raymond 4, Prostate Cancer Cellular Therapy Program Investigators; Elizabeth O Hexner 1,2,3, Donald L Siegel 3,5, Frederic D Bushman 4, Carl H June #,12,13,14,15, Joseph A Fraietta #,16,17,18,19,20, Naomi B Haas #,21,22;
1 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
2 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
3 Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
4 Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
5 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
6 Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.
7 Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
8 Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA.
9 Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
10 Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
11 NanoString Technologies, Inc., Seattle, WA, USA.
12 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
13 Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
14 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
15 Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.
16 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.
17 Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.
18 Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.
19 Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.
20 Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.
21 Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. naomi.haas@pennmedicine.upenn.edu.
22 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. naomi.haas@pennmedicine.upenn.edu.
# Contributed equally.
